CRG and Clayco to Develop, Design and Build Pfizer R&D and Process Development Facility

By on July 17, 2017

CRG is providing turnkey build-to-suit services to complete the new BioPlace for Pfizer in Chesterfield, Missouri. CRG is collaborating with Clayco, the design-builder on the project, for this world-class office and laboratory space.  As one of the world’s premier innovative biopharmaceutical companies, Pfizer has entrusted CRG and Clayco to deliver a facility that reflects its highest standards for excellence, quality, safety and value.

The dual-purpose structure will be comprised of 285,000 square feet of laboratory and office space. The design partnership of Forum Studio and Ewing Cole merged the expertise and talents of both firms where the unique combination of both research and development labs combined with office and meeting spaces creates one of the most progressive facilities in the pharma industry. The architecture, landscape design, engineering, interior and lab/process was also designed by Forum and EwingCole.

The new campus will be owned by Pfizer and will bring together more than 450 employees who currently work at multiple locations that the company leases in the St. Louis area. Pfizer expects to hire an additional 80 employees over the coming years to support research at the site. Construction is expected to be complete by mid-2019.

“Our team came together quickly; the great chemistry was easy to see and the results we’re achieving are proof that true integration within a develop-design-build project can outshine more traditional methods of delivery,” said Kirk Warden, Clayco executive vice president and partner. “The collaboration between developers, designers, builders, engineers and the many owner groups is leading to a state-of-the-art facility that will offer the St. Louis Pfizer family a spacious and collaborative environment with great views into the surrounding wooded property and plenty of daylight reaching every interior space.”

Representatives from Clayco, alongside Pfizer officials and local dignitaries, broke ground on the project June 27, 2017. When complete, the facility will provide approximately 285,000 square feet of R&D space to house Pfizer’s BioTherapeutics Pharmaceutical Sciences group and enabling partners. New state-of-the-art features of the campus will include a floor plan that provides flexible laboratory layouts, scientific casework and utility hookups, open office and collaboration spaces and increased conferencing technologies where researchers can collaborate. Renderings of the new site can be found here. 

CRG is a leading North American real estate developer headquartered in St. Louis, Missouri with offices in Chicago, Sacramento, Atlanta, Pittsburgh and Northern New Jersey. The CRG team has developed more than 5,000 acres of land and delivered over 160 million square feet of commercial, industrial, multi-family and institutional assets exceeding $9 billion in value.

Clayco is a full-service, turnkey real estate development, master planning, architecture, engineering and construction firm that delivers clients around the world the highest quality solutions on time, on budget, and above and beyond expectations. With $1.691 billion in revenue for 2016, Clayco specializes in the “art and science of building,” providing fast track, efficient solutions globally for commercial, institutional and residential related building projects. For more information visit www.claycorp.com.

Forum Studio focuses on enhancing the quality of the human experience and how design can impact each individual’s emotional being. By harnessing the power of integrated design, including architecture, workplace strategy, interior design, landscape architecture, urban planning and engineering we achieve our client’s goals and aspirations. We design for life and build our clients’ dreams. Forum Studio is the art + science of building.

EwingCole, in practice for over 55 years, is a nationally recognized, fully integrated architecture, engineering, interior design, and planning firm of more than 300 professionals in Charlotte, Irvine, New York, Philadelphia, Pittsburgh, and Raleigh. Our multi-disciplinary practice is built on the core values of professional excellence, design quality, and collaboration. We work with our clients’ scientists and facility engineers to deliver research and development environments that meet schedule and budget, while fulfilling future needs for adaptability to evolving scientific technologies.

 

Share Article... Tweet about this on TwitterShare on LinkedInShare on FacebookPin on PinterestEmail this to someone

Leave a Reply

Your email address will not be published. Required fields are marked *